Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Vamil Divan's Stock Ratings
Guggenheim Analyst
Vamil Divan is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/17/2025
Overall Average Return
14.3%
Smart Score
Overall Average Return Percentile
71st
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/16/2025 | JBIO | Buy Now | Jade Biosciences | $8.10 | 72.81% | Vamil Divan74% | → $14 | Upgrade | Neutral → Buy | Get Alert |
| 05/28/2025 | SVRA | Buy Now | Savara | $2.06 | 288.35% | Vamil Divan74% | $9 → $8 | Maintains | Buy | Get Alert |
| 05/20/2025 | AMGN | Buy Now | Amgen | $290.34 | -0.81% | Vamil Divan74% | → $288 | Assumes | → Neutral | Get Alert |
| 05/12/2025 | ANIP | Buy Now | ANI Pharmaceuticals | $63.35 | 35.75% | Vamil Divan74% | $86 → $86 | Reiterates | Buy → Buy | Get Alert |
| 05/08/2025 | VALN | Buy Now | Valneva | $6.02 | 132.56% | Vamil Divan74% | $15 → $14 | Maintains | Buy | Get Alert |
| 04/29/2025 | ABBV | Buy Now | AbbVie | $185.28 | 16.58% | Vamil Divan74% | $214 → $216 | Maintains | Buy | Get Alert |
| 04/21/2025 | UNCY | Buy Now | Unicycive Therapeutics | $0.67 | 795.52% | Vamil Divan74% | → $6 | Initiates | → Buy | Get Alert |
| 04/17/2025 | MRK | Buy Now | Merck & Co | $77.96 | 47.52% | Vamil Divan74% | $115 → $115 | Reiterates | Buy → Buy | Get Alert |
| 04/17/2025 | ABBV | Buy Now | AbbVie | $185.28 | 15.5% | Vamil Divan74% | $214 → $214 | Reiterates | Buy → Buy | Get Alert |
| 04/14/2025 | TVTX | Buy Now | Travere Therapeutics | $14.09 | 233.69% | Vamil Divan74% | $47 → $47 | Reiterates | Buy → Buy | Get Alert |
| 04/11/2025 | ANIP | Buy Now | ANI Pharmaceuticals | $63.35 | 35.75% | Vamil Divan74% | $86 → $86 | Reiterates | Buy → Buy | Get Alert |
| 04/02/2025 | JNJ | Buy Now | Johnson & Johnson | $152.49 | — | Vamil Divan74% | — | Reiterates | Neutral → Neutral | Get Alert |
| 03/25/2025 | ASMB | Buy Now | Assembly Biosciences | $17.15 | 80.76% | Vamil Divan74% | → $31 | Initiates | → Buy | Get Alert |
| 03/20/2025 | ABSI | Buy Now | Absci | $2.71 | 269% | Vamil Divan74% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2025 | PFE | Buy Now | Pfizer | $24.00 | — | Vamil Divan74% | — | Reiterates | Buy → Buy | Get Alert |
| 03/12/2025 | PFE | Buy Now | Pfizer | $24.00 | — | Vamil Divan74% | — | Reiterates | Buy → Buy | Get Alert |
| 03/12/2025 | JNJ | Buy Now | Johnson & Johnson | $152.49 | — | Vamil Divan74% | — | Reiterates | Neutral → Neutral | Get Alert |
| 03/10/2025 | JNJ | Buy Now | Johnson & Johnson | $152.49 | — | Vamil Divan74% | — | Reiterates | Neutral → Neutral | Get Alert |
| 03/05/2025 | ANIP | Buy Now | ANI Pharmaceuticals | $63.35 | 35.75% | Vamil Divan74% | $84 → $86 | Maintains | Buy | Get Alert |
| 02/27/2025 | VERA | Buy Now | Vera Therapeutics | $20.90 | 191.87% | Vamil Divan74% | $59 → $61 | Maintains | Buy | Get Alert |
| 02/25/2025 | INSM | Buy Now | Insmed | $100.14 | 0.86% | Vamil Divan74% | $101 → $101 | Reiterates | Buy → Buy | Get Alert |
| 02/12/2025 | MRK | Buy Now | Merck & Co | $77.96 | 47.52% | Vamil Divan74% | $122 → $115 | Maintains | Buy | Get Alert |
| 02/10/2025 | PFE | Buy Now | Pfizer | $24.00 | 37.5% | Vamil Divan74% | $33 → $33 | Reiterates | Buy → Buy | Get Alert |
| 02/07/2025 | INSM | Buy Now | Insmed | $100.14 | 0.86% | Vamil Divan74% | $95 → $101 | Maintains | Buy | Get Alert |
| 02/03/2025 | ABBV | Buy Now | AbbVie | $185.28 | 15.5% | Vamil Divan74% | $212 → $214 | Maintains | Buy | Get Alert |
| 02/03/2025 | JNJ | Buy Now | Johnson & Johnson | $152.49 | 8.86% | Vamil Divan74% | $162 → $166 | Maintains | Neutral | Get Alert |
| 01/17/2025 | ABBV | Buy Now | AbbVie | $185.28 | 14.42% | Vamil Divan74% | $221 → $212 | Maintains | Buy | Get Alert |
| 01/17/2025 | KROS | Buy Now | Keros Therapeutics | $13.46 | — | Vamil Divan74% | — | Reiterates | Neutral → Neutral | Get Alert |
| 12/16/2024 | KROS | Buy Now | Keros Therapeutics | $13.46 | — | Vamil Divan74% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/11/2024 | PFE | Buy Now | Pfizer | $24.00 | 37.5% | Vamil Divan74% | $35 → $33 | Maintains | Buy | Get Alert |
| 12/10/2024 | RVNC | Buy Now | Revance Therapeutics | — | — | Vamil Divan74% | $6.66 → $3.1 | Maintains | Neutral | Get Alert |
| 12/05/2024 | KROS | Buy Now | Keros Therapeutics | $13.46 | 657.8% | Vamil Divan74% | $96 → $102 | Maintains | Buy | Get Alert |
| 12/04/2024 | KROS | Buy Now | Keros Therapeutics | $13.46 | — | Vamil Divan74% | — | Reiterates | Buy → Buy | Get Alert |
| 12/03/2024 | ABSI | Buy Now | Absci | $2.71 | 269% | Vamil Divan74% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2024 | JNJ | Buy Now | Johnson & Johnson | $152.49 | 6.24% | Vamil Divan74% | $156 → $162 | Maintains | Neutral | Get Alert |
| 11/06/2024 | ABBV | Buy Now | AbbVie | $185.28 | 19.28% | Vamil Divan74% | $212 → $221 | Maintains | Buy | Get Alert |
| 10/28/2024 | VERA | Buy Now | Vera Therapeutics | $20.90 | 206.22% | Vamil Divan74% | $56 → $64 | Maintains | Buy | Get Alert |
| 10/09/2024 | TVTX | Buy Now | Travere Therapeutics | $14.09 | 191.09% | Vamil Divan74% | $23 → $41 | Maintains | Buy | Get Alert |
| 10/02/2024 | ABSI | Buy Now | Absci | $2.71 | 269% | Vamil Divan74% | → $10 | Initiates | → Buy | Get Alert |
| 09/27/2024 | TVTX | Buy Now | Travere Therapeutics | $14.09 | 63.29% | Vamil Divan74% | $25 → $23 | Maintains | Buy | Get Alert |
| 09/23/2024 | KROS | Buy Now | Keros Therapeutics | $13.46 | 613.22% | Vamil Divan74% | → $96 | Initiates | → Buy | Get Alert |
| 09/10/2024 | PROK | Buy Now | ProKidney | $0.94 | 534.92% | Vamil Divan74% | → $6 | Initiates | → Buy | Get Alert |
| 09/09/2024 | TVTX | Buy Now | Travere Therapeutics | $14.09 | 77.49% | Vamil Divan74% | → $25 | Upgrade | Neutral → Buy | Get Alert |
| 07/09/2024 | INSM | Buy Now | Insmed | $100.14 | -5.13% | Vamil Divan74% | $70 → $95 | Maintains | Buy | Get Alert |
| 06/18/2024 | AVTE | Buy Now | Aerovate Therapeutics | — | — | Vamil Divan74% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/10/2024 | RVNC | Buy Now | Revance Therapeutics | — | — | Vamil Divan74% | $9 → $8 | Maintains | Neutral | Get Alert |
| 04/23/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $63.35 | 21.55% | Vamil Divan74% | $77 → $77 | Reiterates | Buy → Buy | Get Alert |
| 04/09/2024 | ALPN | Buy Now | Alpine Immune Sciences | — | — | Vamil Divan74% | → $55 | Initiates | → Buy | Get Alert |
| 04/05/2024 | VERA | Buy Now | Vera Therapeutics | $20.90 | 167.94% | Vamil Divan74% | $56 → $56 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2024 | VERA | Buy Now | Vera Therapeutics | $20.90 | 167.94% | Vamil Divan74% | $27 → $56 | Maintains | Buy | Get Alert |
| 03/27/2024 | TVTX | Buy Now | Travere Therapeutics | $14.09 | — | Vamil Divan74% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/22/2024 | ABBV | Buy Now | AbbVie | $185.28 | 2.55% | Vamil Divan74% | $188 → $190 | Maintains | Buy | Get Alert |
| 03/05/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $63.35 | 21.55% | Vamil Divan74% | $70 → $77 | Maintains | Buy | Get Alert |
| 02/27/2024 | INSM | Buy Now | Insmed | $100.14 | -46.08% | Vamil Divan74% | $52 → $54 | Maintains | Buy | Get Alert |
| 02/23/2024 | PFE | Buy Now | Pfizer | $24.00 | 50% | Vamil Divan74% | → $36 | Initiates | → Buy | Get Alert |
| 01/29/2024 | RVNC | Buy Now | Revance Therapeutics | — | — | Vamil Divan74% | $16 → $9 | Downgrade | Buy → Neutral | Get Alert |
| 01/26/2024 | KRTX | Buy Now | Karuna Therapeutics | — | — | Vamil Divan74% | $245 → $330 | Downgrade | Buy → Neutral | Get Alert |
| 10/19/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $63.35 | 13.65% | Vamil Divan74% | → $72 | Reiterates | Buy → Buy | Get Alert |
| 09/22/2023 | TVTX | Buy Now | Travere Therapeutics | $14.09 | 27.8% | Vamil Divan74% | $25 → $18 | Maintains | Buy | Get Alert |
| 09/13/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $63.35 | 13.65% | Vamil Divan74% | → $72 | Reiterates | Buy → Buy | Get Alert |
| 09/07/2023 | SAGE | Buy Now | Sage Therapeutics | $9.10 | 119.78% | Vamil Divan74% | $19 → $20 | Maintains | Neutral | Get Alert |
| 09/05/2023 | INSM | Buy Now | Insmed | $100.14 | -48.07% | Vamil Divan74% | $50 → $52 | Reiterates | Buy → Buy | Get Alert |
| 08/18/2023 | CALT | Buy Now | Calliditas Therapeutics | — | — | Vamil Divan74% | $21 → $18 | Maintains | Neutral | Get Alert |
| 08/16/2023 | VERA | Buy Now | Vera Therapeutics | $20.90 | 29.19% | Vamil Divan74% | → $27 | Initiates | → Buy | Get Alert |
| 08/10/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $63.35 | 13.65% | Vamil Divan74% | $62 → $72 | Maintains | Buy | Get Alert |
| 08/08/2023 | SAGE | Buy Now | Sage Therapeutics | $9.10 | 108.79% | Vamil Divan74% | $45 → $19 | Maintains | Neutral | Get Alert |
| 07/27/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $63.35 | -2.13% | Vamil Divan74% | $59 → $62 | Maintains | Buy | Get Alert |
| 07/26/2023 | INSM | Buy Now | Insmed | $100.14 | -50.07% | Vamil Divan74% | → $50 | Initiates | → Buy | Get Alert |
| 06/15/2023 | RLMD | Buy Now | Relmada Therapeutics | $0.74 | 3413.51% | Vamil Divan74% | → $26 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | Vamil Divan74% | $35 → $40 | Downgrade | Buy → Neutral | Get Alert |
| 06/07/2023 | RVNC | Buy Now | Revance Therapeutics | — | — | Vamil Divan74% | $33 → $35 | Maintains | Buy | Get Alert |
| 05/09/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $63.35 | -6.87% | Vamil Divan74% | $55 → $59 | Maintains | Buy | Get Alert |
| 05/02/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | Vamil Divan74% | $43 → $35 | Maintains | Buy | Get Alert |
| 05/02/2023 | TVTX | Buy Now | Travere Therapeutics | $14.09 | 63.29% | Vamil Divan74% | $40 → $23 | Maintains | Buy | Get Alert |
| 04/28/2023 | ABBV | Buy Now | AbbVie | $185.28 | -7.71% | Vamil Divan74% | $172 → $171 | Maintains | Buy | Get Alert |
| 04/03/2023 | SCYX | Buy Now | SCYNEXIS | $0.75 | 1098.24% | Vamil Divan74% | $8 → $9 | Maintains | Buy | Get Alert |
| 03/01/2023 | SCYX | Buy Now | SCYNEXIS | $0.75 | 965.1% | Vamil Divan74% | → $8 | Initiates | → Buy | Get Alert |
| 03/01/2023 | CALT | Buy Now | Calliditas Therapeutics | — | — | Vamil Divan74% | → $18 | Initiates | → Neutral | Get Alert |
| 03/01/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | Vamil Divan74% | → $43 | Initiates | → Buy | Get Alert |
| 03/01/2023 | AVTE | Buy Now | Aerovate Therapeutics | — | — | Vamil Divan74% | → $36 | Initiates | → Buy | Get Alert |
| 03/01/2023 | GOSS | Buy Now | Gossamer Bio | $1.24 | — | Vamil Divan74% | — | Initiates | → Neutral | Get Alert |
| 03/01/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $63.35 | -13.18% | Vamil Divan74% | → $55 | Initiates | → Buy | Get Alert |
| 03/01/2023 | JNJ | Buy Now | Johnson & Johnson | $152.49 | 5.58% | Vamil Divan74% | → $161 | Initiates | → Neutral | Get Alert |
| 03/01/2023 | ABBV | Buy Now | AbbVie | $185.28 | -7.17% | Vamil Divan74% | → $172 | Initiates | → Buy | Get Alert |
| 03/01/2023 | TVTX | Buy Now | Travere Therapeutics | $14.09 | 162.69% | Vamil Divan74% | → $37 | Initiates | → Buy | Get Alert |
| 02/17/2023 | SAGE | Buy Now | Sage Therapeutics | $9.10 | 394.51% | Vamil Divan74% | $37 → $45 | Maintains | Neutral | Get Alert |
| 11/15/2022 | STSA | Buy Now | Satsuma Pharma | — | — | Vamil Divan74% | $13 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 09/09/2022 | RVNC | Buy Now | Revance Therapeutics | — | — | Vamil Divan74% | $26 → $30 | Maintains | Buy | Get Alert |
| 08/10/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $23.00 | -17.39% | Vamil Divan74% | $27 → $19 | Maintains | Neutral | Get Alert |
| 08/09/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $23.00 | -17.39% | Vamil Divan74% | $27 → $19 | Maintains | Neutral | Get Alert |
| 08/09/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | Vamil Divan74% | $190 → $276 | Maintains | Buy | Get Alert |
| 08/08/2022 | NBIX | Buy Now | Neurocrine Biosciences | $124.88 | -21.52% | Vamil Divan74% | $95 → $98 | Maintains | Neutral | Get Alert |
| 07/28/2022 | ALKS | Buy Now | Alkermes | $29.77 | 14.21% | Vamil Divan74% | $36 → $34 | Maintains | Buy | Get Alert |
| 05/25/2022 | CABA | Buy Now | Cabaletta Bio | $1.91 | 423.56% | Vamil Divan74% | $20 → $10 | Maintains | Buy | Get Alert |
| 05/13/2022 | STSA | Buy Now | Satsuma Pharma | — | — | Vamil Divan74% | $15 → $13 | Maintains | Buy | Get Alert |
| 05/11/2022 | RVNC | Buy Now | Revance Therapeutics | — | — | Vamil Divan74% | → $26 | Maintains | Buy | Get Alert |
| 05/03/2022 | AXSM | Buy Now | Axsome Therapeutics | $101.60 | -51.77% | Vamil Divan74% | $51 → $49 | Maintains | Buy | Get Alert |
| 05/02/2022 | LLY | Buy Now | Eli Lilly | $790.62 | -54.97% | Vamil Divan74% | $315 → $356 | Maintains | Buy | Get Alert |
| 04/27/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | Vamil Divan74% | $178 → $190 | Maintains | Buy | Get Alert |
| 04/19/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $23.00 | 17.39% | Vamil Divan74% | $28 → $27 | Maintains | Neutral | Get Alert |
| 03/18/2022 | CABA | Buy Now | Cabaletta Bio | $1.91 | 947.12% | Vamil Divan74% | $22 → $20 | Maintains | Buy | Get Alert |
| 03/16/2022 | XERS | Buy Now | Xeris Biopharma Holdings | $4.59 | 30.76% | Vamil Divan74% | $8 → $6 | Maintains | Buy | Get Alert |
| 03/03/2022 | SAGE | Buy Now | Sage Therapeutics | $9.10 | 350.55% | Vamil Divan74% | $44 → $41 | Maintains | Neutral | Get Alert |
| 03/03/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | Vamil Divan74% | $182 → $178 | Maintains | Buy | Get Alert |
| 03/03/2022 | BHVN | Buy Now | Biohaven | $14.57 | 956.96% | Vamil Divan74% | $144 → $154 | Maintains | Buy | Get Alert |
| 03/03/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $23.00 | 21.74% | Vamil Divan74% | $33 → $28 | Maintains | Neutral | Get Alert |
| 02/04/2022 | ABBV | Buy Now | AbbVie | $185.28 | -10.41% | Vamil Divan74% | $154 → $166 | Maintains | Buy | Get Alert |
| 02/04/2022 | LLY | Buy Now | Eli Lilly | $790.62 | -62.94% | Vamil Divan74% | $302 → $293 | Maintains | Buy | Get Alert |
| 01/05/2022 | ABBV | Buy Now | AbbVie | $185.28 | -16.88% | Vamil Divan74% | $132 → $154 | Maintains | Buy | Get Alert |
| 12/14/2021 | PFE | Buy Now | Pfizer | $24.00 | 133.33% | Vamil Divan74% | $44 → $56 | Maintains | Neutral | Get Alert |
| 12/07/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $23.00 | 13.04% | Vamil Divan74% | $24 → $26 | Maintains | Neutral | Get Alert |
| 11/18/2021 | BHVN | Buy Now | Biohaven | $14.57 | 888.33% | Vamil Divan74% | $135 → $144 | Maintains | Buy | Get Alert |
| 11/18/2021 | RLMD | Buy Now | Relmada Therapeutics | $0.74 | 6656.76% | Vamil Divan74% | → $50 | Initiates | → Buy | Get Alert |
| 11/10/2021 | BHVN | Buy Now | Biohaven | $14.57 | 826.56% | Vamil Divan74% | $137 → $135 | Maintains | Buy | Get Alert |
| 11/05/2021 | KRTX | Buy Now | Karuna Therapeutics | — | — | Vamil Divan74% | $150 → $182 | Maintains | Buy | Get Alert |
| 11/02/2021 | NBIX | Buy Now | Neurocrine Biosciences | $124.88 | -17.52% | Vamil Divan74% | $99 → $103 | Maintains | Neutral | Get Alert |
| 11/01/2021 | ABBV | Buy Now | AbbVie | $185.28 | -28.76% | Vamil Divan74% | $131 → $132 | Maintains | Buy | Get Alert |
| 09/01/2021 | ABBV | Buy Now | AbbVie | $185.28 | -29.3% | Vamil Divan74% | → $131 | Reiterates | → Buy | Get Alert |
| 08/10/2021 | AXSM | Buy Now | Axsome Therapeutics | $101.60 | -45.87% | Vamil Divan74% | $118 → $55 | Maintains | Buy | Get Alert |
| 08/04/2021 | LLY | Buy Now | Eli Lilly | $790.62 | -64.71% | Vamil Divan74% | $250 → $279 | Maintains | Buy | Get Alert |
| 08/02/2021 | ABBV | Buy Now | AbbVie | $185.28 | -29.3% | Vamil Divan74% | $128 → $131 | Maintains | Buy | Get Alert |
| 07/30/2021 | PFE | Buy Now | Pfizer | $24.00 | 79.17% | Vamil Divan74% | $42 → $43 | Maintains | Neutral | Get Alert |
| 07/29/2021 | ALKS | Buy Now | Alkermes | $29.77 | 10.85% | Vamil Divan74% | $29 → $33 | Maintains | Buy | Get Alert |
| 07/12/2021 | BHVN | Buy Now | Biohaven | $14.57 | 819.69% | Vamil Divan74% | $92 → $134 | Maintains | Buy | Get Alert |
| 06/30/2021 | CABA | Buy Now | Cabaletta Bio | $1.91 | 1051.83% | Vamil Divan74% | → $22 | Initiates | → Buy | Get Alert |
| 06/22/2021 | STSA | Buy Now | Satsuma Pharma | — | — | Vamil Divan74% | $7 → $15 | Upgrade | Neutral → Buy | Get Alert |
| 05/28/2021 | BHVN | Buy Now | Biohaven | $14.57 | 531.43% | Vamil Divan74% | $90 → $92 | Maintains | Buy | Get Alert |
| 05/11/2021 | BHVN | Buy Now | Biohaven | $14.57 | 517.7% | Vamil Divan74% | $98 → $90 | Maintains | Buy | Get Alert |
| 05/06/2021 | EOLS | Buy Now | Evolus | $9.20 | 63.04% | Vamil Divan74% | → $15 | Upgrade | Neutral → Buy | Get Alert |
| 05/06/2021 | PFE | Buy Now | Pfizer | $24.00 | 75% | Vamil Divan74% | → $42 | Downgrade | Buy → Neutral | Get Alert |
| 05/03/2021 | ABBV | Buy Now | AbbVie | $185.28 | -30.92% | Vamil Divan74% | $126 → $128 | Maintains | Buy | Get Alert |
| 04/28/2021 | LLY | Buy Now | Eli Lilly | $790.62 | -72.68% | Vamil Divan74% | $228 → $216 | Maintains | Buy | Get Alert |
| 04/26/2021 | NBIX | Buy Now | Neurocrine Biosciences | $124.88 | -7.11% | Vamil Divan74% | $119 → $116 | Maintains | Neutral | Get Alert |
| 04/26/2021 | BHVN | Buy Now | Biohaven | $14.57 | 572.61% | Vamil Divan74% | $103 → $98 | Maintains | Buy | Get Alert |
| 04/06/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $23.00 | 8.7% | Vamil Divan74% | → $25 | Downgrade | Buy → Neutral | Get Alert |
| 02/26/2021 | KRTX | Buy Now | Karuna Therapeutics | — | — | Vamil Divan74% | $116 → $150 | Maintains | Buy | Get Alert |
| 02/26/2021 | SAGE | Buy Now | Sage Therapeutics | $9.10 | 790.11% | Vamil Divan74% | → $81 | Downgrade | Buy → Neutral | Get Alert |
| 02/05/2021 | NBIX | Buy Now | Neurocrine Biosciences | $124.88 | -4.71% | Vamil Divan74% | $117 → $119 | Maintains | Neutral | Get Alert |
| 02/04/2021 | ABBV | Buy Now | AbbVie | $185.28 | -31.99% | Vamil Divan74% | $117 → $126 | Maintains | Buy | Get Alert |
| 02/03/2021 | PFE | Buy Now | Pfizer | $24.00 | 75% | Vamil Divan74% | $44 → $42 | Maintains | Buy | Get Alert |
| 02/01/2021 | LLY | Buy Now | Eli Lilly | $790.62 | -71.16% | Vamil Divan74% | $222 → $228 | Maintains | Buy | Get Alert |
| 01/19/2021 | LLY | Buy Now | Eli Lilly | $790.62 | -71.92% | Vamil Divan74% | $164 → $222 | Upgrade | Neutral → Buy | Get Alert |
| 12/16/2020 | AXSM | Buy Now | Axsome Therapeutics | $101.60 | 18.11% | Vamil Divan74% | → $120 | Initiates | → Buy | Get Alert |
| 12/16/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $23.00 | 200% | Vamil Divan74% | → $69 | Initiates | → Buy | Get Alert |
| 12/04/2020 | SAGE | Buy Now | Sage Therapeutics | $9.10 | 790.11% | Vamil Divan74% | $77 → $81 | Upgrade | Neutral → Buy | Get Alert |
| 11/17/2020 | LLY | Buy Now | Eli Lilly | $790.62 | -80.27% | Vamil Divan74% | $164 → $156 | Maintains | Neutral | Get Alert |
| 10/15/2020 | ALKS | Buy Now | Alkermes | $29.77 | -19.38% | Vamil Divan74% | $19 → $24 | Upgrade | Neutral → Buy | Get Alert |
| 09/11/2020 | STSA | Buy Now | Satsuma Pharma | — | — | Vamil Divan74% | $32 → $4 | Downgrade | Buy → Neutral | Get Alert |
| 08/04/2020 | NBIX | Buy Now | Neurocrine Biosciences | $124.88 | 5.7% | Vamil Divan74% | $127 → $132 | Maintains | Neutral | Get Alert |
| 08/03/2020 | ABBV | Buy Now | AbbVie | $185.28 | -40.09% | Vamil Divan74% | $110 → $111 | Maintains | Buy | Get Alert |
| 07/23/2020 | NBIX | Buy Now | Neurocrine Biosciences | $124.88 | 1.7% | Vamil Divan74% | $105 → $127 | Maintains | Neutral | Get Alert |
| 07/07/2020 | EOLS | Buy Now | Evolus | $9.20 | -67.39% | Vamil Divan74% | $8 → $3 | Downgrade | Buy → Neutral | Get Alert |
| 06/29/2020 | ABBV | Buy Now | AbbVie | $185.28 | -40.63% | Vamil Divan74% | $101 → $110 | Maintains | Buy | Get Alert |
| 06/10/2020 | BHVN | Buy Now | Biohaven | $14.57 | 483.39% | Vamil Divan74% | $53 → $85 | Maintains | Buy | Get Alert |
| 05/12/2020 | EOLS | Buy Now | Evolus | $9.20 | -13.04% | Vamil Divan74% | $10 → $8 | Maintains | Buy | Get Alert |
| 05/07/2020 | NBIX | Buy Now | Neurocrine Biosciences | $124.88 | -15.92% | Vamil Divan74% | $103 → $105 | Maintains | Neutral | Get Alert |
| 05/04/2020 | ABBV | Buy Now | AbbVie | $185.28 | -45.49% | Vamil Divan74% | $100 → $101 | Maintains | Buy | Get Alert |
| 04/17/2020 | EOLS | Buy Now | Evolus | $9.20 | 8.7% | Vamil Divan74% | $12 → $10 | Maintains | Buy | Get Alert |
| 04/08/2020 | SAGE | Buy Now | Sage Therapeutics | $9.10 | 295.6% | Vamil Divan74% | $58 → $36 | Maintains | Neutral | Get Alert |
| 02/28/2020 | SAGE | Buy Now | Sage Therapeutics | $9.10 | 537.36% | Vamil Divan74% | $69 → $58 | Maintains | Neutral | Get Alert |
| 02/10/2020 | ABBV | Buy Now | AbbVie | $185.28 | -43.87% | Vamil Divan74% | $96 → $104 | Maintains | Buy | Get Alert |
| 02/06/2020 | ALKS | Buy Now | Alkermes | $29.77 | -36.18% | Vamil Divan74% | → $19 | Initiates | → Neutral | Get Alert |
| 02/06/2020 | SAGE | Buy Now | Sage Therapeutics | $9.10 | 658.24% | Vamil Divan74% | → $69 | Initiates | → Neutral | Get Alert |
| 02/06/2020 | LLY | Buy Now | Eli Lilly | $790.62 | -81.28% | Vamil Divan74% | → $148 | Initiates | → Neutral | Get Alert |
| 02/06/2020 | EOLS | Buy Now | Evolus | $9.20 | 117.39% | Vamil Divan74% | → $20 | Initiates | → Buy | Get Alert |
| 02/06/2020 | NBIX | Buy Now | Neurocrine Biosciences | $124.88 | -14.32% | Vamil Divan74% | → $107 | Initiates | → Neutral | Get Alert |
| 02/06/2020 | PFE | Buy Now | Pfizer | $24.00 | 75% | Vamil Divan74% | → $42 | Initiates | → Buy | Get Alert |
| 02/06/2020 | KRTX | Buy Now | Karuna Therapeutics | — | — | Vamil Divan74% | → $120 | Initiates | → Buy | Get Alert |
| 02/06/2020 | ABBV | Buy Now | AbbVie | $185.28 | -48.19% | Vamil Divan74% | → $96 | Initiates | → Buy | Get Alert |
| 02/06/2020 | STSA | Buy Now | Satsuma Pharma | — | — | Vamil Divan74% | → $37 | Initiates | → Buy | Get Alert |
| 02/06/2020 | BHVN | Buy Now | Biohaven | $14.57 | 325.53% | Vamil Divan74% | → $62 | Initiates | → Buy | Get Alert |
| 12/13/2019 | GLPG | Buy Now | Galapagos | $27.92 | — | Vamil Divan74% | — | Downgrade | Outperform → Neutral | Get Alert |
| 11/08/2019 | ALNA | Buy Now | Allena Pharmaceuticals | — | — | Vamil Divan74% | $7 → $4 | Downgrade | Outperform → Neutral | Get Alert |
| 10/24/2019 | JNJ | Buy Now | Johnson & Johnson | $152.49 | 6.89% | Vamil Divan74% | $158 → $163 | Maintains | Outperform | Get Alert |
| 10/16/2019 | JNJ | Buy Now | Johnson & Johnson | $152.49 | 3.61% | Vamil Divan74% | $156 → $158 | Maintains | Outperform | Get Alert |
| 09/17/2019 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Vamil Divan74% | $11 → $19 | Reiterates | → Neutral | Get Alert |
| 09/06/2019 | ALNA | Buy Now | Allena Pharmaceuticals | — | — | Vamil Divan74% | $26 → $7 | Maintains | Outperform | Get Alert |
| 08/05/2019 | ALNA | Buy Now | Allena Pharmaceuticals | — | — | Vamil Divan74% | → $26 | Assumes | → Outperform | Get Alert |
| 08/05/2019 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Vamil Divan74% | → $35 | Assumes | → Neutral | Get Alert |
| 07/12/2019 | JNJ | Buy Now | Johnson & Johnson | $152.49 | 2.3% | Vamil Divan74% | → $156 | Initiates | → Outperform | Get Alert |
| 07/10/2019 | ALNA | Buy Now | Allena Pharmaceuticals | — | — | Vamil Divan74% | — | Assumes | → Outperform | Get Alert |
| 07/10/2019 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Vamil Divan74% | — | Assumes | → Neutral | Get Alert |
| 07/10/2019 | GLPG | Buy Now | Galapagos | $27.92 | — | Vamil Divan74% | — | Assumes | → Outperform | Get Alert |
| 07/10/2019 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.88 | — | Vamil Divan74% | — | Assumes | → Neutral | Get Alert |
| 07/10/2019 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Vamil Divan74% | — | Assumes | → Neutral | Get Alert |
| 05/21/2019 | AIMT | Buy Now | Aimmune Therapeutics | — | — | Vamil Divan74% | $36 → $30 | Assumes | → Outperform | Get Alert |
| 05/16/2019 | JNJ | Buy Now | Johnson & Johnson | $152.49 | 2.3% | Vamil Divan74% | $152 → $156 | Maintains | Outperform | Get Alert |
| 04/17/2019 | JNJ | Buy Now | Johnson & Johnson | $152.49 | -0.32% | Vamil Divan74% | $151 → $152 | Maintains | Outperform | Get Alert |
| 03/07/2019 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | $161 → $155 | Maintains | Neutral | Get Alert |
| 02/14/2019 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.88 | 18.48% | Vamil Divan74% | $26 → $20 | Maintains | Neutral | Get Alert |
| 01/31/2019 | PFE | Buy Now | Pfizer | $24.00 | — | Vamil Divan74% | — | Upgrade | Neutral → Outperform | Get Alert |
| 01/31/2019 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | $197 → $161 | Downgrade | Outperform → Neutral | Get Alert |
| 01/08/2019 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | $200 → $197 | Maintains | Outperform | Get Alert |
| 12/13/2018 | GLPG | Buy Now | Galapagos | $27.92 | — | Vamil Divan74% | — | Upgrade | Neutral → Outperform | Get Alert |
| 12/13/2018 | ALKS | Buy Now | Alkermes | $29.77 | 4.13% | Vamil Divan74% | $47 → $31 | Downgrade | Outperform → Underperform | Get Alert |
| 11/08/2018 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Vamil Divan74% | $34 → $30 | Maintains | Neutral | Get Alert |
| 11/06/2018 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Vamil Divan74% | $19 → $17 | Maintains | Neutral | Get Alert |
| 10/31/2018 | PFE | Buy Now | Pfizer | $24.00 | 75% | Vamil Divan74% | $40 → $42 | Maintains | Neutral | Get Alert |
| 10/31/2018 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | $213 → $202 | Maintains | Outperform | Get Alert |
| 10/31/2018 | LLY | Buy Now | Eli Lilly | $790.62 | — | Vamil Divan74% | — | Upgrade | Underperform → Neutral | Get Alert |
| 10/26/2018 | GLPG | Buy Now | Galapagos | $27.92 | 222.35% | Vamil Divan74% | $92 → $90 | Maintains | Neutral | Get Alert |
| 10/17/2018 | JNJ | Buy Now | Johnson & Johnson | $152.49 | -0.32% | Vamil Divan74% | $149 → $152 | Maintains | Outperform | Get Alert |
| 10/11/2018 | MRK | Buy Now | Merck & Co | $77.96 | 3.9% | Vamil Divan74% | $71 → $81 | Maintains | Outperform | Get Alert |
| 09/17/2018 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.88 | 54.03% | Vamil Divan74% | $23 → $26 | Maintains | Neutral | Get Alert |
| 09/07/2018 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.88 | 36.26% | Vamil Divan74% | $25 → $23 | Downgrade | Outperform → Neutral | Get Alert |
| 08/27/2018 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Vamil Divan74% | $28 → $34 | Upgrade | Underperform → Neutral | Get Alert |
| 08/15/2018 | CRVS | Buy Now | Corvus Pharma | $4.25 | 252.94% | Vamil Divan74% | → $15 | Assumes | Neutral → Outperform | Get Alert |
| 08/13/2018 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Vamil Divan74% | $16 → $19 | Maintains | Outperform | Get Alert |
| 08/13/2018 | AIMT | Buy Now | Aimmune Therapeutics | — | — | Vamil Divan74% | $47 → $40 | Maintains | Outperform | Get Alert |
| 08/10/2018 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Vamil Divan74% | $49 → $28 | Downgrade | Outperform → Underperform | Get Alert |
| 08/07/2018 | GLPG | Buy Now | Galapagos | $27.92 | 229.51% | Vamil Divan74% | $85 → $92 | Maintains | Neutral | Get Alert |
| 08/01/2018 | PFE | Buy Now | Pfizer | $24.00 | 66.67% | Vamil Divan74% | $39 → $40 | Maintains | Neutral | Get Alert |
| 07/27/2018 | BMY | Buy Now | Bristol-Myers Squibb | $47.18 | 29.29% | Vamil Divan74% | $58 → $61 | Maintains | Neutral | Get Alert |
| 07/27/2018 | ALKS | Buy Now | Alkermes | $29.77 | 71.31% | Vamil Divan74% | $57 → $51 | Maintains | Outperform | Get Alert |
| 07/25/2018 | LLY | Buy Now | Eli Lilly | $790.62 | -89.12% | Vamil Divan74% | $84 → $86 | Maintains | Underperform | Get Alert |
| 06/21/2018 | LLY | Buy Now | Eli Lilly | $790.62 | -89.38% | Vamil Divan74% | $82 → $84 | Maintains | Underperform | Get Alert |
| 05/30/2018 | ABBV | Buy Now | AbbVie | $185.28 | -51.96% | Vamil Divan74% | $104 → $89 | Downgrade | Neutral → Underperform | Get Alert |
| 05/03/2018 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | $215 → $213 | Maintains | Outperform | Get Alert |
| 04/27/2018 | ABBV | Buy Now | AbbVie | $185.28 | -43.87% | Vamil Divan74% | $109 → $104 | Maintains | Neutral | Get Alert |
| 04/20/2018 | JNJ | Buy Now | Johnson & Johnson | $152.49 | -0.98% | Vamil Divan74% | $154 → $151 | Maintains | Outperform | Get Alert |
| 03/28/2018 | ALNA | Buy Now | Allena Pharmaceuticals | — | — | Vamil Divan74% | $22 → $21 | Maintains | Outperform | Get Alert |
| 03/13/2018 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Vamil Divan74% | $53 → $49 | Maintains | Outperform | Get Alert |
| 03/05/2018 | AIMT | Buy Now | Aimmune Therapeutics | — | — | Vamil Divan74% | $45 → $47 | Maintains | Outperform | Get Alert |
| 02/21/2018 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Vamil Divan74% | $68 → $53 | Maintains | Outperform | Get Alert |
| 02/14/2018 | MRK | Buy Now | Merck & Co | $77.96 | -16.62% | Vamil Divan74% | $66 → $65 | Maintains | Outperform | Get Alert |
| 02/12/2018 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.88 | 36.26% | Vamil Divan74% | $20 → $23 | Maintains | Outperform | Get Alert |
| 02/12/2018 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.88 | — | Vamil Divan74% | — | Upgrade | Neutral → Outperform | Get Alert |
| 02/07/2018 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | $214 → $215 | Maintains | Outperform | Get Alert |
| 02/05/2018 | MRK | Buy Now | Merck & Co | $77.96 | -15.34% | Vamil Divan74% | $67 → $66 | Maintains | Outperform | Get Alert |
| 01/31/2018 | PFE | Buy Now | Pfizer | $24.00 | 62.5% | Vamil Divan74% | $37 → $39 | Maintains | Neutral | Get Alert |
| 01/22/2018 | LLY | Buy Now | Eli Lilly | $790.62 | — | Vamil Divan74% | — | Downgrade | Neutral → Underperform | Get Alert |
| 01/17/2018 | ESPR | Buy Now | Esperion Therapeutics | $1.09 | 9349.54% | Vamil Divan74% | → $103 | Initiates | → Outperform | Get Alert |
| 12/15/2017 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.88 | — | Vamil Divan74% | — | Upgrade | Underperform → Neutral | Get Alert |
| 11/27/2017 | ALNA | Buy Now | Allena Pharmaceuticals | — | — | Vamil Divan74% | → $22 | Initiates | → Outperform | Get Alert |
| 11/06/2017 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.88 | -52.61% | Vamil Divan74% | $14 → $8 | Maintains | Underperform | Get Alert |
| 11/06/2017 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | $243 → $224 | Maintains | Outperform | Get Alert |
| 10/27/2017 | ALKS | Buy Now | Alkermes | $29.77 | 121.7% | Vamil Divan74% | $70 → $66 | Maintains | Outperform | Get Alert |
| 10/27/2017 | BMY | Buy Now | Bristol-Myers Squibb | $47.18 | 29.29% | Vamil Divan74% | $58 → $61 | Maintains | Neutral | Get Alert |
| 10/23/2017 | AIMT | Buy Now | Aimmune Therapeutics | — | — | Vamil Divan74% | $36 → $45 | Maintains | Outperform | Get Alert |
| 10/19/2017 | JNJ | Buy Now | Johnson & Johnson | $152.49 | 0.99% | Vamil Divan74% | $147 → $154 | Maintains | Outperform | Get Alert |
| 10/17/2017 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | $266 → $243 | Maintains | Outperform | Get Alert |
| 10/10/2017 | LLY | Buy Now | Eli Lilly | $790.62 | — | Vamil Divan74% | — | Downgrade | Outperform → Neutral | Get Alert |
| 09/26/2017 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | $286 → $266 | Maintains | Outperform | Get Alert |
| 09/19/2017 | MYOK | Buy Now | MyoKardia | — | — | Vamil Divan74% | $45 → $55 | Maintains | Outperform | Get Alert |
| 09/08/2017 | MRK | Buy Now | Merck & Co | $77.96 | -6.36% | Vamil Divan74% | $74 → $73 | Maintains | Outperform | Get Alert |
| 09/06/2017 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.88 | -17.06% | Vamil Divan74% | $13 → $14 | Maintains | Underperform | Get Alert |
| 08/30/2017 | MRK | Buy Now | Merck & Co | $77.96 | -5.08% | Vamil Divan74% | $75 → $74 | Maintains | Outperform | Get Alert |
| 08/24/2017 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Vamil Divan74% | — | Upgrade | Neutral → Outperform | Get Alert |
| 08/24/2017 | CRVS | Buy Now | Corvus Pharma | $4.25 | — | Vamil Divan74% | — | Upgrade | Underperform → Neutral | Get Alert |
| 08/24/2017 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.88 | — | Vamil Divan74% | — | Downgrade | Neutral → Underperform | Get Alert |
| 08/04/2017 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.88 | — | Vamil Divan74% | — | Downgrade | Outperform → Neutral | Get Alert |
| 07/20/2017 | PFE | Buy Now | Pfizer | $24.00 | 50% | Vamil Divan74% | $38 → $36 | Maintains | Neutral | Get Alert |
| 07/20/2017 | JNJ | Buy Now | Johnson & Johnson | $152.49 | -2.94% | Vamil Divan74% | → $148 | Reinstates | → Outperform | Get Alert |
| 07/20/2017 | PFE | Buy Now | Pfizer | $24.00 | — | Vamil Divan74% | — | Downgrade | Outperform → Neutral | Get Alert |
| 05/01/2017 | CRVS | Buy Now | Corvus Pharma | $4.25 | — | Vamil Divan74% | — | Downgrade | Outperform → Underperform | Get Alert |
| 03/20/2017 | ESPR | Buy Now | Esperion Therapeutics | $1.09 | — | Vamil Divan74% | — | Upgrade | Underperform → Neutral | Get Alert |
| 12/20/2016 | VSAR | Buy Now | Versartis | — | — | Vamil Divan74% | $11 → $20 | Upgrade | Neutral → Outperform | Get Alert |
| 10/31/2016 | ABBV | Buy Now | AbbVie | $185.28 | — | Vamil Divan74% | — | Downgrade | Outperform → Neutral | Get Alert |
| 10/31/2016 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.88 | — | Vamil Divan74% | — | Upgrade | Neutral → Outperform | Get Alert |
| 10/17/2016 | BMY | Buy Now | Bristol-Myers Squibb | $47.18 | — | Vamil Divan74% | — | Maintains | Neutral | Get Alert |
| 08/19/2016 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Vamil Divan74% | $30 → $25 | Maintains | Neutral | Get Alert |
| 08/07/2016 | MRK | Buy Now | Merck & Co | $77.96 | -6.36% | Vamil Divan74% | $62 → $73 | Upgrade | Neutral → Outperform | Get Alert |
| 08/07/2016 | BMY | Buy Now | Bristol-Myers Squibb | $47.18 | 33.53% | Vamil Divan74% | $86 → $63 | Downgrade | Outperform → Neutral | Get Alert |
| 07/25/2016 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | → $327 | Initiates | → Outperform | Get Alert |
| 06/29/2016 | ESPR | Buy Now | Esperion Therapeutics | $1.09 | 817.43% | Vamil Divan74% | $23 → $10 | Downgrade | Neutral → Underperform | Get Alert |
| 05/31/2016 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Vamil Divan74% | $33 → $30 | Downgrade | Outperform → Neutral | Get Alert |
| 05/09/2016 | PFE | Buy Now | Pfizer | $24.00 | 62.5% | Vamil Divan74% | $38 → $39 | Maintains | Outperform | Get Alert |
| 05/09/2016 | MRK | Buy Now | Merck & Co | $77.96 | -26.88% | Vamil Divan74% | $56 → $57 | Maintains | Neutral | Get Alert |
| 05/09/2016 | BMY | Buy Now | Bristol-Myers Squibb | $47.18 | 67.44% | Vamil Divan74% | $75 → $79 | Maintains | Outperform | Get Alert |
| 05/04/2016 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.88 | 255.45% | Vamil Divan74% | → $60 | Initiates | → Neutral | Get Alert |
| 05/01/2016 | LLY | Buy Now | Eli Lilly | $790.62 | -88.49% | Vamil Divan74% | $94 → $91 | Maintains | Outperform | Get Alert |
| 05/01/2016 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Vamil Divan74% | $40 → $38 | Maintains | Outperform | Get Alert |
| 04/18/2016 | CRVS | Buy Now | Corvus Pharma | $4.25 | 488.24% | Vamil Divan74% | → $25 | Initiates | → Outperform | Get Alert |
| 03/29/2016 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Vamil Divan74% | → $40 | Maintains | Outperform | Get Alert |
| 03/28/2016 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Vamil Divan74% | $47 → $34 | Maintains | Outperform | Get Alert |
| 12/17/2015 | VSAR | Buy Now | Versartis | — | — | Vamil Divan74% | $20 → $12 | Downgrade | Neutral → Underperform | Get Alert |
| 10/09/2015 | LLY | Buy Now | Eli Lilly | $790.62 | -86.72% | Vamil Divan74% | $89 → $105 | Upgrade | Neutral → Outperform | Get Alert |
| 09/28/2015 | GLPG | Buy Now | Galapagos | $27.92 | 64.76% | Vamil Divan74% | $62 → $46 | Downgrade | Outperform → Neutral | Get Alert |
| 08/20/2015 | VSAR | Buy Now | Versartis | — | — | Vamil Divan74% | → $20 | Initiates | → Neutral | Get Alert |
| 08/19/2015 | VSAR | Buy Now | Versartis | — | — | Vamil Divan74% | → $20 | Initiates | → Neutral | Get Alert |
| 06/24/2015 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Vamil Divan74% | → $50 | Assumes | → Outperform | Get Alert |
| 06/24/2015 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Vamil Divan74% | → $51 | Assumes | → Outperform | Get Alert |
| 06/23/2015 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Vamil Divan74% | → $51 | Initiates | → Outperform | Get Alert |
| 05/06/2015 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Vamil Divan74% | → $36 | Assumes | → Outperform | Get Alert |
| 12/17/2014 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Vamil Divan74% | $19 → $34 | Maintains | Outperform | Get Alert |
| 12/08/2014 | ALKS | Buy Now | Alkermes | $29.77 | 111.62% | Vamil Divan74% | $56 → $63 | Maintains | Outperform | Get Alert |
| 08/06/2014 | ABBV | Buy Now | AbbVie | $185.28 | -66% | Vamil Divan74% | $60 → $63 | Maintains | Outperform | Get Alert |
| 07/31/2014 | MRK | Buy Now | Merck & Co | $77.96 | -24.32% | Vamil Divan74% | $56 → $59 | Maintains | Neutral | Get Alert |
| 06/20/2014 | ABBV | Buy Now | AbbVie | $185.28 | -67.62% | Vamil Divan74% | $58 → $60 | Maintains | Outperform | Get Alert |
| 06/03/2014 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | — | Downgrade | Outperform → Neutral | Get Alert |
| 06/02/2014 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Vamil Divan74% | → $20 | Initiates | → Outperform | Get Alert |
| 05/08/2014 | PFE | Buy Now | Pfizer | $24.00 | 45.83% | Vamil Divan74% | $36 → $35 | Maintains | Outperform | Get Alert |
| 05/08/2014 | MRK | Buy Now | Merck & Co | $77.96 | -28.17% | Vamil Divan74% | $57 → $56 | Maintains | Neutral | Get Alert |
| 05/02/2014 | PFE | Buy Now | Pfizer | $24.00 | 50% | Vamil Divan74% | $34 → $36 | Maintains | Outperform | Get Alert |
| 04/28/2014 | MRK | Buy Now | Merck & Co | $77.96 | -26.88% | Vamil Divan74% | $54 → $57 | Maintains | Outperform | Get Alert |
| 04/10/2014 | ALKS | Buy Now | Alkermes | $29.77 | 104.9% | Vamil Divan74% | $56 → $61 | Upgrade | Neutral → Buy | Get Alert |
| 04/02/2014 | ALKS | Buy Now | Alkermes | $29.77 | 91.47% | Vamil Divan74% | → $57 | Initiates | → Outperform | Get Alert |
| 02/11/2014 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | $123 → $140 | Maintains | Outperform | Get Alert |
| 12/20/2013 | BMY | Buy Now | Bristol-Myers Squibb | $47.18 | 27.17% | Vamil Divan74% | $56 → $60 | Maintains | Outperform | Get Alert |
| 12/12/2013 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | $104 → $112 | Maintains | Outperform | Get Alert |
| 10/08/2013 | PFE | Buy Now | Pfizer | $24.00 | 41.67% | Vamil Divan74% | → $34 | Initiates | → Outperform | Get Alert |
| 10/08/2013 | MRK | Buy Now | Merck & Co | $77.96 | -37.14% | Vamil Divan74% | → $49 | Initiates | → Neutral | Get Alert |
| 10/08/2013 | LLY | Buy Now | Eli Lilly | $790.62 | -93.42% | Vamil Divan74% | → $52 | Initiates | → Neutral | Get Alert |
| 10/08/2013 | BMY | Buy Now | Bristol-Myers Squibb | $47.18 | 16.57% | Vamil Divan74% | → $55 | Initiates | → Outperform | Get Alert |
| 10/08/2013 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | → $104 | Initiates | → Outperform | Get Alert |
| 10/08/2013 | ABBV | Buy Now | AbbVie | $185.28 | -70.85% | Vamil Divan74% | → $54 | Initiates | → Outperform | Get Alert |
| 07/10/2013 | PFE | Buy Now | Pfizer | $24.00 | 29.17% | Vamil Divan74% | → $31 | Assumes | → Overweight | Get Alert |
| 06/17/2013 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Vamil Divan74% | → $30 | Initiates | → Outperform | Get Alert |
| 04/18/2013 | ALKS | Buy Now | Alkermes | $29.77 | — | Vamil Divan74% | — | Downgrade | Buy → Neutral | Get Alert |
| 02/07/2013 | PFE | Buy Now | Pfizer | $24.00 | 20.83% | Vamil Divan74% | → $29 | Assumes | → Neutral | Get Alert |
| 01/17/2013 | ALKS | Buy Now | Alkermes | $29.77 | -19.38% | Vamil Divan74% | → $24 | Initiates | → Neutral | Get Alert |
| 11/16/2012 | ALKS | Buy Now | Alkermes | $29.77 | -9.3% | Vamil Divan74% | → $27 | Initiates | → Buy | Get Alert |
| 09/11/2012 | BMY | Buy Now | Bristol-Myers Squibb | $47.18 | -23.7% | Vamil Divan74% | → $36 | Assumes | → Neutral | Get Alert |
| 08/24/2012 | LLY | Buy Now | Eli Lilly | $790.62 | — | Vamil Divan74% | — | Upgrade | Neutral → Outperform | Get Alert |
| 08/09/2012 | MRK | Buy Now | Merck & Co | $77.96 | -39.71% | Vamil Divan74% | $48 → $47 | Maintains | Outperform | Get Alert |
| 03/29/2012 | AGN | Buy Now | Allergan | — | — | Vamil Divan74% | $102 → $104 | Maintains | Outperform | Get Alert |
